
    
      This is a phase III comparative study to evaluate the effectiveness and safety of DA-3801 in
      treatment of the patients with WHO Group II anovulatory infertility failing to clomiphene
      citrate treatment. The study is conducted with following methods: open label,
      active-controlled, randomized, parallel group, comparative.
    
  